Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome

Recruiting N/A Interventional Study
Obesity & Overweight Metabolic Syndrome Gut Dysbiosis Insulin Resistance Dyslipidemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 60
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
50 (estimated)
Sponsor
JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Dietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chain fatty acids (SCFA), bile acids, indoles, and their derivatives, circulate through the circulatory system to the liver,…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Adults aged 20-60 years. * Willingness to provide informed consent. * Willingness to consume Kodo millet porridge daily for 12 weeks. * No planned changes in diet or physical activity during the study. * Overweight or obese (BMI ≥ 25 kg/m²), placing them at risk for metabolic d…
Contacts

Prerana Shridhar Bhat, MSc

+918762399079

preranabhat@jssuni.edu.in

CONTACT

Dr. Rajesh Kumar Thimmulappa, PhD

+91-9972012892

rajeshkt@jssuni.edu.in

CONTACT